Oracle was at the center of all things artificial intelligence (AI) in 2025, and therefore at the center of the investing ...

Though it certainly doesn’t feel like it, Oracle (NASDAQ:ORCL) shares finished 2025 with respectable, market-beating gains ...

Oracle’s cloud and AI pivot drives revenue growth and a strong backlog, but high capex and debt pose risks. Read why I rate ...

Oracle expects its revenue to explode from $67 billion in fiscal 2026 to $225 billion in fiscal 2030 as the company rapidly ...

Wall Street is losing faith in Oracle’s capacity to crank out new server farms for OpenAI, even after the AI giant agreed to ...

Oracle (NYSE:ORCL) looked set to be the newest addition to the $1 trillion club just a few months back in September, where ...

Oracle (ORCL) is a top AI infrastructure stock with booming cloud revenue, major partnerships, and strong growth—see why it’s ...

With a Price to Book ratio of 18.42, which is 1.07x the industry average, Oracle might be considered overvalued in terms of ...

A memo reportedly reveals that the new U.S. investors may wield significantly less influence than anticipated.

Hospitals and health systems are entering a period of rapid acceleration in AI. Clinical leaders are reporting tangible gains, from automated note-taking to clearer visibility into patient histories, ...

Oracle has gone from market darling to market riddle in a matter of months, with a brutal sell‑off colliding head‑on with one ...